Influence
May 15, 2023

Regenstrief researcher featured speaker at UsAgainstAlzheimer’s event in Washington, DC

Dr. Nicole Fowler speaking at the UsAgainstAlzheimer's Brain Health Bash in Washington, D.C.

Regenstrief Research Scientist Nicole Fowler, PhD, MHSA, was the featured speaker at an UsAgainstAlzheimer’s event in Washington, D.C. The event was the inaugural Brain Health Bash which focuses on spotlighting the importance of Alzheimer’s prevention and dementia risk reduction.

Dr. Fowler’s research foci include patient-centered diagnosis and treatment and her goal is to improve the quality of care and quality of life for older adults with dementia and their family caregivers.

UsAgainstAlzheimer’s is a national leader in Alzheimer’s care and focuses on prevention, early detection and diagnosis, and access to treatments – regardless of gender, race, or ethnicity.  The organization seeks to give a voice to patients and caregivers while partnering with the government, scientists, the private sector and their allied organizations. A few notable partners are Eli Lilly and Company, EISAI Co., Alzheimer’s Drug Discovery Foundation and Biogen.

Dr. Fowler standing with Jill Lesser, President, WomenAgainstAlzheimer's, and a top health podcaster Max Lugavere.
Dr. Fowler (left) standing with Jill Lesser, President, WomenAgainstAlzheimer’s, and a top health podcaster Max Lugavere.

During her presentation on April 18, Dr. Fowler, who is also the associate director of the Indiana University Center for Aging Research at Regenstrief Institute and an associate professor at Indiana University School of Medicine, topics discussed were about the data for early detection of dementia, the importance of systems of care and how to ensure persons with dementia and their family that they are supported at all stages of the disease.

As a Regenstrief research scientist, her work is focused on the development, testing and comparison of evidence-based and patient-centered interventions that improve the quality of care for older adults and their family caregivers, in particular medical decision-making interventions to support family caregivers of older adults with Alzheimer’s disease.

Dr. Fowler’s research to has been funded by multiple foundations along with the National Institutes of Health and the U.S. Department of Defense.

About Nicole R. Fowler, PhD, MHSA
In addition to her role as associate director of the Indiana University Center for Aging Research at Regenstrief Institute, Nicole R. Fowler, PhD, MHSA, is also an associate professor of medicine at Indiana University School of Medicine and director of research for the Division of General Internal Medicine and Geriatrics. She also is an implementation scientist in the Center for Health and Innovation and Implementation Science and a scientist at the Indiana Alzheimer Disease Research Center.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight